Noetic Fund

Numinus is a Vancouver-based company founded in 2019 by Payton Nyquvest and Stacey Wallin, specializing in psychedelic-centered therapeutic products and services. It integrates holistic healthcare approaches with neuro-technology to enhance patient care. Numinus operates a network of clinics, including Numinus Health, Mindspace Services, and the Neurology Center of Toronto, offering a range of services such as ketamine-assisted psychotherapy for conditions like depression, as well as neurological care and counseling by registered psychologists. The company is structured into several operational segments, including clinical research, its Canadian and US clinic networks, and corporate functions, with the majority of its revenue generated from the US segment. Through its laboratory and research and development initiatives, Numinus aims to advance the field of psychedelic therapy and improve mental health outcomes.

Diamond Therapeutics is a Toronto-based company dedicated to developing novel therapies for mental health conditions. It focuses on harnessing the potential of psychedelic compounds, specifically sub-perceptual, non-hallucinogenic treatments, aiming to benefit a wide range of patients and maximize positive impact on global mental health.

Wake Network, Inc. is a Toronto-based company that specializes in clinical research and the development of wellness solutions through fungi and plant-based medicine. Founded in June 2018, it combines expertise from wellness professionals and advanced technology to create innovative healing benefits for the mind and body. The company has established a regenerative feedback loop, enabling it to conduct research, monitor outcomes, and integrate findings from clinical studies on a personalized basis. This approach positions Wake Network at the forefront of advancements in mental and holistic health.